tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Les Sulewski, 21 are a BUY (87.5%), 3 are a HOLD (12.5%).
Analyst Les Sulewski, currently employed at TRUIST, carries an average stock price target met ratio of 56.94% that have a potential upside of 29.48% achieved within 124 days.
Les Sulewski’s has documented 47 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 30-Apr-2026.
Analyst best performing recommendations are on XAIR (BEYOND AIR).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK) at 10/25/2023. The price target of $6 was fulfilled within 63 days with a profit of $2.08 (53.06%) receiving and performance score of 8.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Oct-2023
$17
$-0.23 (-1.33%)
$14
4 months 29 days ago
(02-Mar-2026)
6/6 (100%)
$3.23 (23.46%)
212
Buy Since 07-Aug-2023
$13
$-4.23 (-24.55%)
$11
9 months ago
(31-Oct-2025)
8/8 (100%)
$2.18 (20.15%)
413
Buy Since 16-Sep-2025
$14
$-3.23 (-18.75%)
$12
10 months 15 days ago
(16-Sep-2025)
3/3 (100%)
$4.26 (43.74%)
139
Buy Since 14-Dec-2020
$11
$-6.23 (-36.16%)
$10
1 years 4 months 28 days ago
(03-Mar-2025)
7/7 (100%)
$2.24 (25.57%)
712
Buy Since 12-May-2022
$8
$-9.23 (-53.57%)
$6.25
2 years 2 months 25 days ago
(06-May-2024)
6/6 (100%)
$1.35 (20.30%)
169
Which stock is Les Sulewski is most bullish on?
Which stock is Les Sulewski is most reserved on?
What Year was the first public recommendation made by Les Sulewski?
